Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07633067 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine.

Name: Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine. — clinical trial record (NCT07633067)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FAST-EM-2

StatusNot Yet Recruiting

PhaseNot applicable

SponsorThe Affiliated Hospital Of Guizhou Medical University

Started2026-06-15

View on ClinicalTrials.gov ↗

The Affiliated Hospital Of Guizhou Medical University

8 trials monitored

See all monitored trials

Migraine

463 trials monitored

See 25 trials at risk

This study is a multicenter, prospective, double-blind, multi-arm, randomized controlled trial that investigates whether middle meningeal artery embolization is superior to current standard pharmacotherapy for migraine. The main objectives of the study are to explore whether middle meningeal artery embolization can reduce migraine patients' dependence on migraine medications and to assess the safety of middle meningeal artery embolization with coils.

Trial Details

NCT Number	NCT07633067
Lead Sponsor	The Affiliated Hospital Of Guizhou Medical University Collaborators: Sichuan Action Medical Technology Co., Ltd., Juhui Medical Technology (Shenzhen) Co., Ltd., Beijing Xinke Medical Technology Co., Ltd.
Conditions	Migraine
Enrollment	150 participants
Start Date	2026-06-15
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-08